Home › Funds › D. E. Shaw & Co › STRO
D. E. Shaw & Co position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)30.13K sh
Reported value held$1.00M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 37.39K | $706.00K | New |
| Q4 2021 | 30.66K | $456.00K | Reduce |
| Q2 2022 | 259.40K | $1.35M | New |
| Q3 2022 | 315.01K | $1.75M | Add |
| Q4 2022 | 275.59K | $2.23M | Reduce |
| Q1 2023 | 155.20K | $717.02K | Reduce |
| Q2 2023 | 40.72K | $189.36K | Reduce |
| Q1 2024 | 241.64K | $1.37M | New |
| Q2 2024 | 128.66K | $376.99K | Reduce |
| Q3 2024 | 167.65K | $580.05K | Add |
| Q4 2024 | 157.68K | $290.14K | Reduce |
| Q1 2025 | 158.04K | $102.82K | Hold |
| Q2 2026 | 30.13K | $1.00M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026